The improvements happened without any therapy done during the patients’ trip TUESDAY, Sept. 9, 2025 (HealthDay News) — "Flower power" psychedelic drugs might be a potential cure for modern anxiety, ...
A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...
Emily Standley Allard on MSN
Psychedelic therapy’s surprising journey from taboo to mainstream medicine
Psychedelic therapy, involving substances like psilocybin (found in magic mushrooms), MDMA, and ketamine, is gaining recognition as a groundbreaking approach to treating mental health conditions, ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy status to an LSD formula to treat generalized anxiety disorder after an initial study has shown that a single dose of the ...
The “Rerouting Minds” webpage comprises information about LSD’s clinical history dating back to the 1930s, about how ...
MindMed's LSD tartrate receives breakthrough therapy designation from the FDA for the treatment of generalized anxiety disorder. GAD affects a significant portion of the US population, with high costs ...
MindMed Inc. said Tuesday it's on track to launch Phase 3 clinical trials with up to 440 people starting later this year for its treatment of generalized anxiety disorder (GAD) through use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results